Edition:
United States

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,454.50INR
5:59am EDT
Change (% chg)

Rs2.70 (+0.11%)
Prev Close
Rs2,451.80
Open
Rs2,447.05
Day's High
Rs2,468.85
Day's Low
Rs2,428.00
Volume
4,888
Avg. Vol
8,670
52-wk High
Rs3,000.00
52-wk Low
Rs2,201.20

Chart for

About

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The... (more)

Overall

Beta: 0.16
Market Cap(Mil.): Rs207,674.91
Shares Outstanding(Mil.): 84.70
Dividend: 30.00
Yield (%): 1.22

Financials

  Industry Sector
P/E (TTM): -- 31.63 16.86
EPS (TTM): -- -- --
ROI: -- 14.92 11.22
ROE: -- 16.17 15.09

BRIEF-India's Glaxosmithkline Pharmaceuticals June-qtr profit down about 63 pct

* June quarter profit 264.2 million rupees versus profit of 722.7 million rupees last year

Jul 25 2017

BRIEF-India's Glaxosmithkline Pharma March-qtr profit rises about 6 pct

* Says recommended a dividend of 300 pct on equity share capital

May 19 2017

Earnings vs. Estimates